Search for Clinical Trial Results

Sponsored By

Leishmaniasis, Mucocutaneous - 7 Studies Found

Status Study
Completed Study Name: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis
Condition: Leishmaniasis, Mucocutaneous
Date: 2005-05-20
Interventions: Biological: Leish-111f + MPL-SE vaccine
Completed Study Name: Low Antimonial Dosage in American Mucosal Leishmaniasis
Condition:
  • Mucosal Leishmaniasis
  • Mucocutaneous Leish
    Date: 2011-02-20
    Interventions: Drug: Meglumine antimoniate Meglumine antimoniate (Aventis
Completed Study Name: Miltefosine to Treat Mucocutaneous Leishmaniasis
Condition:
  • Mucosal Leishmaniasis
  • Cutaneous Leishmaniasis

Date: 2010-01-12
Interventions: Drug: miltefosine 2.5 mg/kg/day for 28 days
Available Study Name: Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis
Condition:
  • Leishmaniasis, Cutaneous
  • Leishmaniasis, Mucocutaneous
    • Date: 2007-07-27
    Interventions: Drug: sodium stibogluconate (Pentostam) 20 mg/kg IV every day for 20 or 28 days
Completed Study Name: Miltefosine for Mucosal Leishmaniasis
Condition: Leishmaniasis
Date: 2006-09-07
Interventions: Drug: miltefosine 2.5 mg/kg/day for 28 days
Completed Study Name: Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis
Condition: Leishmaniasis
Date: 2006-09-07
Interventions: Drug: miltefosine: 2.5 mg/kg/day for 42 days
Not yet recruiting Study Name: Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia
Condition:
  • Leishmaniasis, Cutaneous
  • Leishmania Braziliensis Complex
  • L
    Date: 2017-03-09
    Interventions:
    • Drug: Paromomycin Sulfate topi